Shufang Zhang Selected Research

Cofilin 1

1/2019	miR-182-5p affects human bladder cancer cell proliferation, migration and invasion through regulating Cofilin 1.
11/2017	Study on the significance of Cofilin 1 overexpression in human bladder cancer.
11/2017	Cofilin 1 promotes bladder cancer and is regulated by TCF7L2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shufang Zhang Research Topics

Disease

28	Neoplasms (Cancer) 09/2022 - 02/2010
11	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 10/2015
8	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2013
7	Infections 09/2021 - 01/2015
6	Osteoarthritis 01/2022 - 08/2012
5	Wounds and Injuries (Trauma) 09/2021 - 08/2012
5	Inflammation (Inflammations) 11/2020 - 04/2015
4	Type 2 Diabetes Mellitus (MODY) 05/2022 - 01/2017
3	Sepsis (Septicemia) 01/2022 - 01/2021
3	Intraabdominal Infections 12/2020 - 09/2013
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2022 - 01/2022
2	AIDS-Related Complex (ARC) 09/2021 - 02/2018
2	Thalassemia 01/2021 - 06/2020
2	Ulcerative Colitis 01/2021 - 10/2019
2	Liver Neoplasms (Liver Cancer) 01/2021 - 12/2013
2	Urinary Tract Infections (Urinary Tract Infection) 12/2020 - 09/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 08/2017
2	Burns 01/2020 - 01/2019
2	Insulin Resistance 01/2020 - 05/2019
2	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 01/2020
2	Pneumonia (Pneumonitis) 01/2020 - 01/2017
2	Heart Failure 11/2019 - 06/2018
2	Myocardial Infarction 11/2019 - 06/2018
2	Septic Shock (Toxic Shock Syndrome) 01/2019 - 01/2014
2	Thrombocytopenia (Thrombopenia) 06/2018 - 06/2012
2	Fibrosis (Cirrhosis) 12/2016 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 04/2014 - 12/2013
1	Osteosarcoma (Osteogenic Sarcoma) 09/2022
1	Lung Injury 01/2022
1	Acute Lung Injury 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Corneal Injuries 12/2021
1	Carcinogenesis 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2020
1	Enterobacteriaceae Infections 12/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2013
7	Pharmaceutical PreparationsIBA 01/2020 - 02/2010
6	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2014
5	CytokinesIBA 01/2022 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2014
4	Long Noncoding RNAIBA 09/2022 - 01/2019
4	Biological ProductsIBA 01/2020 - 10/2015
4	Messenger RNA (mRNA)IBA 01/2020 - 02/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2015
4	MicroRNAs (MicroRNA)IBA 01/2019 - 10/2015
3	Glyburide (Glibenclamide)FDA LinkGeneric 01/2022 - 04/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2015
3	Carbapenems (Carbapenem Antibiotics)IBA 12/2020 - 01/2017
3	Cofilin 1IBA 01/2019 - 11/2017
3	Gefitinib (Iressa)FDA Link 06/2018 - 10/2017
2	LuciferasesIBA 09/2022 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 06/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 06/2020
2	Phytic Acid (Inositol Hexaphosphate)IBA 09/2021 - 02/2018
2	ElectrolytesIBA 09/2021 - 02/2018
2	Monoamine Oxidase (MAO)IBA 09/2021 - 02/2018
2	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2017
2	Imipenem FDA Link 12/2020 - 01/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 04/2015
2	Therapeutic UsesIBA 05/2019 - 01/2018
2	HydrogelsIBA 01/2019 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 06/2018
2	CollagenIBA 10/2017 - 12/2016
2	EnzymesIBA 01/2016 - 01/2015
1	Glucagon-Like Peptide-1 ReceptorIBA 05/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2022
1	GlucocorticoidsIBA 03/2022
1	LipopolysaccharidesIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	InflammasomesIBA 01/2022
1	titanium alloy (TiAl6V4)IBA 09/2021
1	potassium hydroxideIBA 09/2021
1	Sirolimus (Rapamycin)FDA Link 09/2021
1	Hematoxylin (Haematoxylon)IBA 09/2021
1	Interleukin-17 (Interleukin 17)IBA 09/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2021
1	Beclin-1IBA 09/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2021
1	Initiator Codon (Start Codon)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	pevonedistatIBA 01/2021
1	CaspasesIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Caspase 9IBA 01/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2013
4	Drug Therapy (Chemotherapy) 01/2022 - 06/2012
3	Length of Stay 01/2022 - 01/2019
3	Immunotherapy 01/2021 - 08/2014
2	Radiotherapy 01/2021 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 01/2014
1	Intra-Articular Injections 01/2022
1	Castration 01/2021